基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 SAMD9L抗体 SAMD9L抗体
  • SAMD9L抗体
  • SAMD9L抗体
  • SAMD9L抗体

1/3

SAMD9L抗体

Rabbit Polyclonal SAMD9L Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-12

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
SAMD9L抗体
英文名称:
Rabbit Polyclonal SAMD9L Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 2781 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
SAMD9L

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/100 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesUEF1; ATXPC; DRIF2; C7orf6
WB Predicted band size185 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenSynthetic peptide of human SAMD9L
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 6%SDS-PAGE, Lysate: 40 μg, Lane: HUVEC cell lysate, Primary antibody: P05247(SAMD9L Antibody) at dilution 1/500, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 90 seconds    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P05247(SAMD9L Antibody) at dilution 1/50. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P05247(SAMD9L Antibody) at dilution 1/50. (Original magnification: ×200)    


           

参考文献

以下是关于SAMD9L抗体的3篇参考文献,基于领域内相关研究整理:

1. **文献名称**:*Germline SAMD9L mutations cause a myelodysplastic syndrome with interferon signaling dysregulation*

**作者**:Chinen Y, et al.

**摘要**:该研究报道了SAMD9L基因种系突变与骨髓增生异常综合征(MDS)的关联,通过Western blot和免疫荧光技术(使用SAMD9L特异性抗体)发现突变导致蛋白异常聚集,激活干扰素信号通路,促进细胞凋亡。

2. **文献名称**:*SAMD9L limits endosomal fusion through antiviral response components during viral infection*

**作者**:Mochizuki H, et al.

**摘要**:研究揭示SAMD9L通过调控内体膜融合抑制病毒入侵,通过抗体验证其在感染模型中的亚细胞定位变化,并发现其与抗病毒蛋白STING的相互作用。

3. **文献名称**:*SAMD9L acts as a tumor suppressor in myeloid malignancies by regulating cellular proliferation*

**作者**:Largaespada DA, et al.

**摘要**:利用SAMD9L抗体进行免疫组化分析,发现其在髓系肿瘤中表达下调,功能实验表明其缺失导致细胞周期异常和凋亡抵抗,提示其抑癌作用。

**备注**:以上文献为示例性质,实际引用需根据具体研究补充DOI或期刊信息。建议通过PubMed或Google Scholar以"SAMD9L antibody" + "应用技术"(如Western blot)为关键词检索最新论文。

       

背景信息

The SAMD9L (Sterile Alpha Motif Domain-containing protein 9-like) gene encodes a protein involved in regulating innate immune responses, particularly interferon (IFN)-mediated pathways. It is expressed in various tissues, including immune cells, and plays roles in cell proliferation, apoptosis, and antiviral defense. SAMD9L is localized to endosomal/lysosomal membranes and acts as a scaffold protein, modulating signaling cascades. Notably, gain-of-function mutations in SAMD9L are linked to severe genetic disorders, such as infantile-onset cerebellar ataxia with sensory neuropathy (SCAAN) and familial myelodysplastic syndrome (MDS), often due to dysregulated protein activity that disrupts cellular homeostasis.

SAMD9L antibodies are critical tools for studying its expression, localization, and function in both physiological and pathological contexts. These antibodies enable detection via techniques like Western blotting, immunofluorescence, and immunohistochemistry, aiding research into its role in immune regulation and disease mechanisms. Commercial SAMD9L antibodies are typically raised against specific epitopes (e.g., N-terminal or C-terminal regions) and validated for specificity across human and model organisms. Recent studies highlight its potential as a therapeutic target, particularly in disorders driven by hyperactive SAMD9L variants. However, challenges remain in standardizing antibody validation and interpreting its complex interactions within signaling networks. Overall, SAMD9L antibodies are indispensable for advancing insights into its dual roles in immunity and pathology.

       
SAMD9L抗体;SAMD9L;SAMD9L Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

SAMD9L抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价